The effect of a case management intervention on drug treatment entry among treatment-seeking injection drug users with and without comorbid antisocial personality disorder

Journal of Urban Health

Volumn 84, Issue 2, 2007, Pages 267-271

  Havens, Jennifer R ^a   Cornelius, Llewellyn J ^b   Ricketts, Erin P ^c   Latkin, Carl A ^c   Bishai, David ^c   Lloyd, Jacqueline J ^d   Huettner, Steven ^c   Strathdee, Steffanie A ^c,e  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d TEMPLE UNIVERSITY   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Antisocial personality disorder; Case management; Injection drug user

Indexed keywords

OPIATE AGONIST;

ANTISOCIAL BEHAVIOR; ARTICLE; BEHAVIOR THERAPY; CASE MANAGEMENT; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG DEPENDENCE TREATMENT; GENERALIZED ANXIETY DISORDER; HELP SEEKING BEHAVIOR; HUMAN; INTERVENTION STUDY; INTRAVENOUS DRUG ABUSE; MAJOR DEPRESSION; PERSONALITY DISORDER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REHABILITATION CARE; REHABILITATION CENTER; STRUCTURED INTERVIEW; SUBSTANCE ABUSE;

ADULT; ANTISOCIAL PERSONALITY DISORDER; BALTIMORE; CASE MANAGEMENT; DIAGNOSIS, DUAL (PSYCHIATRY); FEMALE; HUMANS; INTERVENTION STUDIES; MALE; MULTIVARIATE ANALYSIS; NARCOTICS; NEEDLE-EXCHANGE PROGRAMS; OPIOID-RELATED DISORDERS; RECEPTORS, OPIOID; RISK-TAKING; SUBSTANCE ABUSE TREATMENT CENTERS; SUBSTANCE ABUSE, INTRAVENOUS; TIME FACTORS; URBAN HEALTH SERVICES;

EID: 33947226761     PISSN: 10993460     EISSN: 14682869     Source Type: Journal    
DOI: 10.1007/s11524-006-9144-4     Document Type: Article

References (16)

1. Brooner RK, Greenfield L, Schmidt CW, Bigelow GE. Antisocial personality disorder and HIV infection among intravenous drug abusers. Am J Psychiatry. 1993;150:53-58.
2. Booth RE, Corsi KF, Mikulich SK. Improving entry to methadone maintenance among out-of-treatment injection drug users. J Subst Abuse Treat. 2003;24:305-311.
3. Dinwiddie SH, Cottler L, Compton W, Abdallah AB. Psychopathology and HIV risk behaviors among injection drug users in and out of treatment. Drug Alcohol Depend. 1996;43:1-11.
4. Gill K, Nolimal D, Crowley TJ. Antisocial personality disorder, HIV risk behavior and retention in methadone maintenance therapy. Drug Alcohol Depend. 1992;30:247-252.
5. Bell J, Mattick R, Hay A, Chan J, Hall W. Methadone maintenance and drug-related crime. J Subst Abuse. 1997;9:15-25.
6. Goodwin RD, Hamilton SP. Lifetime comorbidity of antisocial personality disorder and anxiety disorders among adults in the community. Psychiatry Res. 2003;117:159-166.
7. Brooner R, King V, Kidorf M, Schmidt CW, Bigelow GE. Psychiatric and substance use comorbidity among treatment-seeking opioid abusers. Arch Gen Psychiatry. 1997;54:71-80.
8. RachBeisel J, Scott J, Dixon L. Co-occurring severe mental illness and substance use disorders: a review of recent research. Psychiatr Serv. 1999;50:1427-1434.
9. Havens JR, Strathdee SA. Antisocial personality disorder and opioid treatment outcomes: a review. Addict Disord Treat. 2005;4:85-97.
10. Robins LN. The intimate connection between antisocial personality and substance abuse. Soc Psychiatry Psychiatr Epidemiol. 1998;33:393-399.
11. Strathdee SA, Ricketts EP, Huettner S, et al. Facilitating entry into drug treatment among injection drug users referred from a needle exchange program: results from a community-based behavioral intervention trial. Drug Alcohol Depend. 2006;83:225-232.
12. Rapp RC, Siegal HA, Fisher JH. A strengths-based model of case management/advocacy: adapting a mental health model to practice work with persons who have substance abuse problems. NIDA Res Monogr. 1992;127:79-91.
13. First MB, Spitzer RL, Gibbon M, Williams JB. The Structured Clinical Interview for DSM-III-R Personality Disorders (SCID-II), Part I: description. J Personal Disord. 1995;9:92-104.
14. Spitzer RL, Williams JB, Gibbon M, First MB. The Structured Clinical Interview for DSMIII-R (SCID). I: history, rationale, and description. Arch Gen Psychiatry. 1992;49:624-629.
15. Strain EC, Stitzer ML, Bigelow GE. Early treatment time course of depressive symptoms in opiate addicts. J Nerv Ment Dis. 1991;179:215-221.
16. Sorensen JL, Copeland AL. Drug abuse treatment as an HIV prevention strategy: a review. Drug Alcohol Depend. 2000;59:17-31.